DC
IMGN

Deere & Company’s Immunogen Inc IMGN Stock Holding History

Deere & Company’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,064
Closed -$180K – 1046
2014
Q1 		$180K Hold
12,064
– – 0.01% 875
2013
Q4 		$177K Buy
+12,064
New +$185K 0.01% 949

Other funds holding IMGN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deere & Company's IMGN Position: Q2 2014 in Review

Deere & Company sold out of Immunogen Inc (IMGN) in Q2 2014, closing a stake of 12,064 shares — an estimated $180K sold.

Deere & Company first reported a position in IMGN in Q4 2013 and held it in 2 quarters. The position peaked at $180K in Q1 2014. 137 funds tracked by Wall St. Rank hold IMGN as of Q2 2014.

  • Deere & Company reported no remaining Immunogen Inc position as of Q2 2014 after selling out during the quarter.
  • Deere & Company sold 12,064 Immunogen Inc shares in Q2 2014, an estimated $180K.
  • Deere & Company first reported a position in Immunogen Inc in Q4 2013 and held it in 2 quarters.
  • Deere & Company's Immunogen Inc position peaked at $180K in Q1 2014.
  • 137 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2014.

Based on Deere & Company's 13F filing for Q2 2014, filed 11 Aug 2014.